Clozapine Augmentation with Antipsychotics among Patients with Schizophrenia Spectrum Disorders in the Ontario Forensic Psychiatry System
Patients with severe symptoms and significant risk profiles were more likely to receive CAA. Capacity development and further research are needed to support an effective and safe clozapine therapy strategy.
Authors
- Mark Mohan Kaggwa (ORCID: https://orcid.org/0000-0002-4733-154X)
- Gary Chaimowitz (ORCID: https://orcid.org/0000-0002-8035-7530)
- Joan Abaatyo (ORCID: https://orcid.org/0000-0002-2968-7307)
- Andrew T Olagunju (ORCID: https://orcid.org/0000-0003-1736-9886)
- Precious Agboinghale
- Tolulope Oladimeji
- John MW Bradford
Institutions
- St. Joseph’s Healthcare Hamilton (CA)
- Uganda Christian University (UG)
Publication Details
- Journal
- Archives of Medical Research
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1016/j.arcmed.2025.103365
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 33.12